---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-063124"
form_type: "8-K"
ticker: "ZBH"
cik: "0001136869"
company_name: "ZIMMER BIOMET HOLDINGS, INC."
filed_at: "2025-05-05T23:59:59+00:00"
generated_at: "2026-05-22T16:31:49.722590+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Zimmer Biomet Q1 rev +1.1%; guides 2025 adj EPS down to $7.90-$8.10, rev up including Paragon 28

## Summary
- Q1 net sales $1.909B (+1.1% reported, +2.3% CC); GAAP EPS $0.91, adjusted EPS $1.81.
- 2025 adjusted EPS guidance lowered to $7.90-$8.10 from $8.15-$8.35 due to Paragon 28, currency, and tariffs.
- 2025 reported revenue guidance raised to 5.7%-8.2% (includes Paragon 28); organic CC unchanged at 3%-5%.
- Completed acquisition of Paragon 28 (foot and ankle orthopedics) in Q1 2025.
- Chairman Begley retiring at May 29 meeting; CEO Tornos to become Chairman, Farrell Lead Independent Director.

## SEC filing metadata
- accession: 0000950170-25-063124
- form_type: 8-K
- ticker: ZBH
- cik: 0001136869
- company_name: ZIMMER BIOMET HOLDINGS, INC.
- filed_at: 2025-05-05T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1136869/000095017025063124/0000950170-25-063124-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1136869/000095017025063124/zbh-20250505.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-063124
- JSON: https://secwatch.observer/filing/0000950170-25-063124.json
- Plain text: https://secwatch.observer/filing/0000950170-25-063124.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.